Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction

Diabetes and Vascular Disease Research

Volumn 5, Issue 4, 2008, Pages 269-275

  Kosiborod, Mikhail ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

Acute myocardial infarction; Diabetes; Epidemiology; Glucose; Insulin; Outcomes; Review

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ACUTE HEART INFARCTION; CAUSE OF DEATH; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; FASTING; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT;

EID: 56249093845     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2008.039     Document Type: Review

References (52)

1. Datey K, Nanda N. Hyperglycemia after acute myocardial infarction: its relation to diabetes mellitus. N Engl J Med 1967;276:262-5.
2. Kosiborod M, Rathore SS, Inzucchi SE et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005;111:3078-86.
3. Bellodi G, Manicardi V, Malavasi V et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989;64:885-8.
4. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 35:773-8.
5. Foo K, Cooper J, Deaner A et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003;89:512-16.
6. Iwakura K, Ito H, Ikushima M et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003;41(1):1-7.
7. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med 1993;94:265-73.
8. Madsen JK, Haunsoe S, Helquist S et al. Prevalence of hyperglycaemia and undiagnosed diabetes mellitus in patients with acute myocardial infarction. Acta Med Scand 1986;220:329-32.
9. Mak KH, Mah PK, Tey BH, Sin FL, Chia G. Fasting blood sugar level: a determinant for in-hospital outcome in patients with first myocardial infarction and without glucose intolerance. Ann Acad Med Singapore 1993;22:291-5.
10. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991;B14:758-60.
11. Oswald GA, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984;1:1264-7.
12. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ (Clin Res Ed) 1986;B293:917-22.
13. Sala J, Masia R, Gonzalez de Molina FJ et al. Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission. J Epidemiol Community Health 2002;56:707-12.
14. Sewdarsen M, Jialal I, Vythilingum S, Govender G, Rajput MC. Stress hyperglycaemia is a predictor of abnormal glucose tolerance in Indian patients with acute myocardial infarction. Diabetes Res 1987; 6(1):47-9.
15. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748-54.
16. Yudkin JS, Oswald GA. Stress hyperglycemia and cause of death in non-diabetic patients with myocardial infarction. BMJ (Clin Res Ed) 1987; 294:773.
17. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001;79:207-14.
18. Oswald GA, Yudkin JS. Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes. Diabet Med 1987;4(1):68-70.
19. Wong VW, Ross DL, Park K, Boyages SC, Cheung NW. Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabetes Res Clin Pract 2004;64(2):85-91.
20. Hadjadj S, Coisne D, Mauco G et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 2004;21:305-10.
21. Stranders I, Diamant M, van Gelder RE et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004;164:982-8.
22. Ishihara M, Inoue I, Kawagoe T et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J 2003;146:674-8.
23. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005;26: 1255-61.
24. Kadri Z, Danchin N, Vaur L et al. Major impact of admission glycaemia on 30-day and one-year mortality in non diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart 2006;92:910-15.
25. Suleiman M, Hammerman H, Boulos M et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111:754-60.
26. Meier JJ, Deifuss S, Klamann A, Launhardt V, Schmiegel WH, Nauck MA. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care 2005;28:2551-3.
27. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006;29:765-70.
28. Diaz R, Goyal A, Mehta SR et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA 2007; 298:2399-405.
29. Kosiborod M, Inzucchi SE, Krumholz HM et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008; 117:1018-27.
30. Goyal A, Mahaffey KW, Garg J et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006; 27:1289-97.
31. Deedwania P, Kosiborod M, Barrett E et al. Hyperglycemia and acute coronary syndrome. A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008;25;117:1610-19.
32. Aronson D, Hammerman H, Kapeliovich MR et al. Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function. Diabetes Care 2007;30:960-6.
33. Kosiborod M, Inzucchi S, Clark B et al. National patterns of glucose control among patients hospitalized with acute myocardial infarction. J Am Coll Cardiology 2007;49:1018-183:1283A.
34. van der Horst IC, Nijsten MW, Vogelzang M, Zijlstra F. Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction. Cardiovasc Diabetol 2007;6:2.
35. Porter A, Assali AR, Zahalka A et al. Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus. Am Heart J 2008;155:284-9.
36. Verges B, Zeller M, Dentan G et al. impact of fasting glycemia on short-term prognosis after acute myocardial infarction. J Clin Endocrinol Metab 2007;92:2136-40.
37. Selvin E, Marinopoulos S, Berkenblit G et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.
38. Cao JJ, Hudson M, Jankowski M, Whitehouse F, Weaver WD. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 2005; 96:183-6.
39. Vogelzang M, van der Horst IC, Nijsten MW. Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care 2004;8: R122-R127.
40. Chaudhuri A, Janicke D, Wilson MF et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004;109:849-54.
41. Koskenkari JK, Kaukoranta PK, Rimpilainen J et al. Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery. Acta Anaesthesiol Scand 2006;50:962-9.
42. Visser L, Zuurbier CJ, Hoek FJ et al. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaes 2005;95:448-57.
43. Wong VW, McLean M, Boyages SC, Cheung NW. C-reactive protein levels following acute myocardial infarction: effect of insulin infusion and tight glycemic control. Diabetes Care 2004;27:2971-3.
44. Gao F, Gao E, Yue TL et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002;105:1497-502.
45. Jonassen AK, Aasum E, Riemersma RA, Mjos OD, Larsen TS. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Therapy 2000;14:615-23.
46. Jonassen AK, Brar BK, Mjos OD, Sack MN, Latchman DS, Yellon DM. Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Molec Cell Cardiol 2000;32:757-64.
47. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circulation Res 2001;89: 1191-8.
48. Lautamaki R, Airaksinen KE, Seppanen M et al. Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease. Diabetes 2006;55:511-16.
49. Weston C, Walker L, Birkhead J. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart 2007;93:1542-6.
50. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997;314: 1512-15.
51. Kosiborod M, Inzucchi S, Clark B, Krumholz H, Jones P, Spertus J. Variability in the hospital use of insulin to control sustained hyperglycemia among acute myocardial infarction patients. J Am Coll Cardiol 2007;49:1018-186:1284A.
52. Pinto DS, Skolnick AH, Kirtane AJ et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 46:178-80.